Recombinant multi-species B4GALT5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B4GALT5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The function of the enzyme encoded by this gene is not clear. This gene was previously designated as B4GALT4 but was renamed to B4GALT5. In the literature it is also referred to as beta4GalT2. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 4-GalT II,4-GalTase 5,4-galactosyltransferase,4-galactosyltransferase 5,9430078I07Rik,B4GALT5,B4Gal-T5,B4galt5,BETA4-GALT-IV,Beta-1,Beta4Gal-T5,Glucosylceramide beta-1,Lactosylceramide synthase (LacCer synthase),UDP-Gal:beta-GlcNAc beta-1,UDP-galactose:beta-N-acetylglucosamine beta-1,b4Gal-T5,beta4Gal-T5,beta4GalT-V,gt-V

Target products collectionGo to B4GALT5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0042-Ag-1/ GM-Tg-hg-SE0042-Ag-2 Human B4GALT5 protein Human
GM-Tg-rg-SE0042-Ag-1/ GM-Tg-rg-SE0042-Ag-2 Rat B4GALT5 protein Rat
GM-Tg-mg-SE0042-Ag-1/ GM-Tg-mg-SE0042-Ag-2 Mouse B4GALT5 protein Mouse
GM-Tg-cynog-SE0042-Ag-1/ GM-Tg-cynog-SE0042-Ag-2 Cynomolgus/Rhesus macaque B4GALT5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0042-Ag-1/ GM-Tg-felg-SE0042-Ag-2 Feline B4GALT5 protein Feline
GM-Tg-cang-SE0042-Ag-1/ GM-Tg-cang-SE0042-Ag-2 Canine B4GALT5 protein Canine
GM-Tg-bovg-SE0042-Ag-1/ GM-Tg-bovg-SE0042-Ag-2 Bovine B4GALT5 protein Bovine
GM-Tg-equg-SE0042-Ag-1/ GM-Tg-equg-SE0042-Ag-2 Equine B4GALT5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0042-Ag-1/ GM-Tg-hg-SE0042-Ag-2; GM-Tg-rg-SE0042-Ag-1/ GM-Tg-rg-SE0042-Ag-2;
GM-Tg-mg-SE0042-Ag-1/ GM-Tg-mg-SE0042-Ag-2; GM-Tg-cynog-SE0042-Ag-1/ GM-Tg-cynog-SE0042-Ag-2;
GM-Tg-felg-SE0042-Ag-1/ GM-Tg-felg-SE0042-Ag-2; GM-Tg-cang-SE0042-Ag-1/ GM-Tg-cang-SE0042-Ag-2;
GM-Tg-bovg-SE0042-Ag-1/ GM-Tg-bovg-SE0042-Ag-2; GM-Tg-equg-SE0042-Ag-1/ GM-Tg-equg-SE0042-Ag-2
Products Name B4GALT5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name B4GALT5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B4GALT5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.